Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1233-2022Class II

Centricity PACS RA1000

GE Healthcare / initiated 2022-04-28 / Open, Classified / root cause: software

GE Healthcare, LLC began a recall of Centricity PACS RA1000 on . FDA classified it as Class II and gives the reason as "Potential for Distance and Area measurements to display inaccurate measurement values when performed on magnified images, and specific to ZFP, Distance and Area measurements can display inaccurate measurement values...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as software.

Recall record

Recall number
Z-1233-2022
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
GE Healthcare
Product
Centricity PACS RA1000
Product code
LLZ System, Image Processing, Radiological
Reason for recall
Potential for Distance and Area measurements to display inaccurate measurement values when performed on magnified images, and specific to ZFP, Distance and Area measurements can display inaccurate measurement values when performed on lossy images that are scaled down from their original resolution.
Root cause tag
software
FDA root cause
Software design
Action
GE Healthcare notified consignees on about 04/28/2022 via letter titled "URGENT MEDICAL DEVICE CORRECTION." The letter outlined two safety issues and instructed customers to continue to use the device in accordance with the User Manuals, but for issue #1, do not rely on measurements displayed in the viewer. They should manually calibrate the image to create a measurement calibration reference and then perform necessary measurements. For issue #2, do not perform measurements on lossy images. In both instances, customers were requested to complete and return the acknowledgment form to [email protected]. A second letter was sent to customers on about 02/24/2023, to provide instructions for downloading the user manual addendum for CWeb.
Quantity in commerce
676 units
Distribution
Worldwide distribution. Nationwide distribution to AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY. International distribution to Argentina, Australia, Austria, Bahamas, Belgium, Bermuda, Bolivia, Plurinational State of, Brazil, Canada, Chile, China, Colombia, Costa Rica, Denmark, Dominican Republic, Ecuador, Egypt, Finland, France, Germany, Hong Kong, Hungary, India, Indonesia, Ireland, Israel, Italy, Japan, Kazakhstan, Korea, South, Kuwait, Lebanon, Malaysia, Malta, Mexico, Namibia, Netherlands, Nigeria, Norway, Pakistan, Panama, Peru, Poland, Portugal, Puerto Rico, Qatar, Russia, Russian Federation, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Trinidad And Tobago, Turkey, United Arab Emirates, United Kingdom, Uruguay, Venezuela, Bolivarian Republic of, Vietnam
Product codes and lots
a. Software Version 3.0 through 3.2 SP8, No GTIN/DI (Code: 2051372-0XX, 2064678-0XX) b. Software Version 4.0 through 4.0 SP14, GTIN/DI 00840682124447 (Code: 2062264-0XX); c. 6.0 through 6.0 SP10.3, GTIN/DI: 00840682104821 (Code: 2094628-0XX); d. 7.0 through 7.0 SP0.0.4.7, GTIN/DI: 00840682145558 (Code: 5824366-0XX)

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1233-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1229-2022Class IIOngoingVoluntary: Firm initiated
Z-1230-2022Class IIOngoingVoluntary: Firm initiated
Z-1231-2022Class IIOngoingVoluntary: Firm initiated
Z-1232-2022Class IIOngoingVoluntary: Firm initiated
Z-1233-2022Class IIOngoingVoluntary: Firm initiated